IR @ Nirma University
Keeping in tune the global developments we are creating an institutional repository using DSpace Software (Digital Library Software). We are archiving institutional knowledge like, faculty papers, theses, and dissertations in PDF format at DSpace. Students can access this digital information anywhere in the campus.
Please use this identifier to cite or link to this item:
http://10.1.7.192:80/jspui/handle/123456789/9678| Title: | Recent Advances In Treatment of Triple Negative Breast Cancer |
| Authors: | Bhatt, Jeel M. |
| Keywords: | PPR00958 B. Pharm Project Report Pharmaceutics Cancer Breast Cancer Immunananotherapy Immunocheckpoint receptors Nano technology |
| Issue Date: | May-2020 |
| Publisher: | Institute of Pharmacy, Nirma University, A'bad |
| Series/Report no.: | PPR00958; |
| Abstract: | Brest cancer is worldwide most common originates of cancer death in women.Triple negative is called beoriginates this type of cancer has negative action of estrogen receptor, progesterone receptor and HER2 receptor. In modern era, one of the advance treatment of TNBC is based on immunananotherapy by working on immune checkpoint receptors and many other ways, treatment using nanotechnology and triple hit approach. Aim of this review is to introduce some recent advances in treatment of triple negative cancer of the breast, their mode of actions and future prospective in cancer drugs. |
| Description: | Guided by Dr.Mohit Shah |
| URI: | http://10.1.7.192:80/jspui/handle/123456789/9678 |
| Appears in Collections: | B. Pharm Project Reports |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PPR00958.pdf | PPR00958 | 2.14 MB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.